Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab.

Trial Profile

Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 22 May 2012

At a glance

  • Drugs Panitumumab (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2011 Actual initiation date (December 2011) added as reported by ClinicalTrials.gov.
    • 04 Oct 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 16 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top